Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ariane Mamguem"'
Autor:
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Mihaelia Ilie, Audrey Hennequin, Clementine Jankowski, Juliette Albuisson, Sophie Nambot, Charles Coutant, Laurent Arnould, Manon Reda, Caroline Truntzer, Sandrine Dabakuyo
Publikováno v:
Breast, Vol 78, Iss , Pp 103789- (2024)
Background: The results of the OlympiA study led to the approval of a PARP inhibitor (olaparib) as adjuvant treatment for early breast cancer (eBC) at high risk of relapse in patients with a germline BRCA1/2 mutation (gBRCAm). However, the proportion
Externí odkaz:
https://doaj.org/article/b67a5194fa204825b8518e79deea3b8e
Autor:
Clémence Feron Agbo, Emerline Assogba, Aurélie Bertaut, Ariane Mamguem Kamga, Charles Coutant, Isabelle Desmoulins, Vincent Dancourt, Tienhan Sandrine Dabakuyo Yonli
Publikováno v:
Preventive Medicine Reports, Vol 34, Iss , Pp 102248- (2023)
Due to the COVID-19 pandemic, and ensuing overcrowding in the French health system, management of patients with COVID-19 was given priority over that of patients with other pathologies, including chronic diseases. The aim of this study was to study t
Externí odkaz:
https://doaj.org/article/b7552af0539b4f66ab787964b85cd7f8
Autor:
Katia Mahiou, Laura Vincent, Karine Peignaux‐Casasnovas, Hélène Costaz, Marie‐Martine Padeano, Alix Amet, Sandrine Dabakuyo, Ariane Mamguem Kamga, Leila Bengrine‐Lefevre, Charles Coutant
Publikováno v:
Cancer Reports, Vol 6, Iss 5, Pp n/a-n/a (2023)
Abstract Background and Objectives There is no international consensus for management of early‐stage cervical cancer (ESCC). This study aimed to retrospectively investigate disease‐free survival (DFS) and overall survival (OS) in patients with ES
Externí odkaz:
https://doaj.org/article/56ee345674de41b2a6b7f1e234bda795
Autor:
Ariane Mamguem Kamga, Oumar Billa, Sylvain Ladoire, Marie-Laure Poillot, Geneviève Jolimoy, Patrick Roignot, Charles Coutant, Isabelle Desmoulins, Marc Maynadie, Tienhan Sandrine Dabakuyo-Yonli
Publikováno v:
Breast, Vol 59, Iss , Pp 79-86 (2021)
Purpose: To identify prognostic factors of invasive–disease free survival (iDFS) in women with non-metastatic hormone receptor positive (HR+) breast cancer (BC) in daily routine practice. Methods: We performed a retrospective study using data from
Externí odkaz:
https://doaj.org/article/af8aca50d9b241b0bcccf0637bef5bdc
Autor:
Isidore Tiandiogo Traoré, Samiratou Ouedraogo, Dramane Kania, Firmin Nongodo Kaboré, Blahima Konaté, Rachel Médah, Hermann Badolo, Nathalie de Rekeneire, Ariane Mamguem Kamga, Armel Poda, Arnaud Eric Diendere, Boukary Ouédraogo, Esperance Ouédraogo, Oumar Billa, Halidou Tinto, Tienhan Sandrine Dabakuyo-Yonli
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background The world has high hopes of vaccination against COVID-19 to protect the population, boost economies and return to normal life. Vaccination programmes are being rolled out in high income countries, but the pandemic continues to pro
Externí odkaz:
https://doaj.org/article/21b2a4ef258f478992eac5908022c1c3
Autor:
Ariane Mamguem Kamga, Leila Bengrine-Lefevre, Valérie Quipourt, Laure Favier, Ariane Darut-Jouve, Sophie Marilier, Patrick Arveux, Isabelle Desmoulins, Tienhan Sandrine Dabakuyo-Yonli
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background With the growing number of older endometrial cancer (EC) and ovarian cancer (OC) survivors, data on long-term health-related quality of life (HRQoL) became an important issue in the management of older patients. So, the aim of thi
Externí odkaz:
https://doaj.org/article/970e40a01fbb4ae1a6dd11eb9bef4010
Autor:
Ariane Mamguem Kamga, Cyril Di Martino, Amelie Anota, Sophie Paget-Bailly, Charles Coutant, Patrick Arveux, Isabelle Desmoulins, Tienhan Sandrine Dabakuyo-Yonli
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Despite its proven efficacy in reducing recurrence and improving survival, adherence to endocrine therapy (ET) is suboptimal in women with breast cancer (BC). Health-related quality of life (HRQoL) in BC has been widely studied an
Externí odkaz:
https://doaj.org/article/55f4fd63e5f6492b88fdfacbad69b360
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carré, Anne, Sellier, Julie, Kamga, Ariane Mamguem, Dabakuyo, Sandrine, Rouffiac, Magali, Coutant, Charles
Publikováno v:
In Gynécologie Obstétrique Fertilité & Sénologie September 2021 49(9):677-683
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.